Privium Fund Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$610K	Hold	119,000	–	–	0.13%	44
2025 Q1	$630K	Hold	119,000	–	–	0.16%	38
2024 Q4	$804K	Buy	119,000 +41,000	+53%	+$277K	0.18%	37
2024 Q3	$514K	Buy	78,000 +26,000	+50%	+$171K	0.13%	49
2024 Q2	$372K	Buy	+52,000	New	+$372K	0.1%	63